PPA
ABBV icon

Pacific Point Advisors’s AbbVie ABBV Stock Holding History

Pacific Point Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$230K Buy
1,055
+15
+1% +$3.33K 0.12% 120
2025
Q4 		$238K Buy
+1,040
New +$237K 0.13% 125

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Pacific Point Advisors's ABBV Position: Q1 2026 in Review

Pacific Point Advisors increased its AbbVie (ABBV) stake by 1.4% in Q1 2026, buying an estimated $3.33K and bringing the position to 1,055 shares worth $230K. The position accounts for 0.12% of the portfolio, ranked #120.

Pacific Point Advisors first reported a position in ABBV in Q4 2025 and has held it in 2 quarters since. The position peaked at $238K in Q4 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Pacific Point Advisors held 1,055 shares of AbbVie worth $230K as of Q1 2026.
  • Pacific Point Advisors bought 15 AbbVie shares in Q1 2026, an estimated $3.33K.
  • AbbVie made up 0.12% of Pacific Point Advisors's portfolio in Q1 2026, its #120 holding.
  • Pacific Point Advisors first reported a position in AbbVie in Q4 2025 and has held it in 2 quarters since.
  • Pacific Point Advisors's AbbVie position peaked at $238K in Q4 2025.
  • 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Pacific Point Advisors's 13F filing for Q1 2026, filed 4 May 2026.